| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obsessive-Compulsive Disorder | 117 | 2021 | 1491 | 7.710 |
Why?
|
| Gyrus Cinguli | 49 | 2024 | 1115 | 3.310 |
Why?
|
| Amygdala | 42 | 2024 | 1354 | 3.090 |
Why?
|
| Stress Disorders, Post-Traumatic | 64 | 2024 | 4575 | 3.000 |
Why?
|
| Tomography, Emission-Computed | 47 | 2006 | 1122 | 2.860 |
Why?
|
| Extinction, Psychological | 20 | 2023 | 371 | 2.780 |
Why?
|
| Fear | 37 | 2023 | 1476 | 2.780 |
Why?
|
| Facial Expression | 20 | 2022 | 508 | 2.690 |
Why?
|
| Prefrontal Cortex | 41 | 2024 | 2219 | 2.590 |
Why?
|
| Magnetic Resonance Imaging | 145 | 2024 | 36426 | 1.870 |
Why?
|
| Emotions | 33 | 2022 | 2739 | 1.860 |
Why?
|
| Phobic Disorders | 15 | 2017 | 439 | 1.780 |
Why?
|
| Brain | 85 | 2024 | 27112 | 1.760 |
Why?
|
| Anxiety Disorders | 24 | 2023 | 2720 | 1.710 |
Why?
|
| Brain Mapping | 69 | 2018 | 6630 | 1.710 |
Why?
|
| Frontal Lobe | 24 | 2015 | 1420 | 1.440 |
Why?
|
| Corpus Striatum | 16 | 2013 | 1235 | 1.430 |
Why?
|
| Pattern Recognition, Visual | 15 | 2013 | 820 | 1.280 |
Why?
|
| Cerebral Cortex | 33 | 2024 | 5777 | 1.180 |
Why?
|
| Depressive Disorder, Major | 23 | 2024 | 4761 | 1.150 |
Why?
|
| Memory Disorders | 17 | 2010 | 1198 | 1.090 |
Why?
|
| Mental Disorders | 21 | 2023 | 6845 | 1.070 |
Why?
|
| Image Processing, Computer-Assisted | 37 | 2018 | 9000 | 1.000 |
Why?
|
| Mental Recall | 22 | 2017 | 1214 | 0.990 |
Why?
|
| Tourette Syndrome | 16 | 2014 | 395 | 0.980 |
Why?
|
| Hippocampus | 30 | 2024 | 3766 | 0.920 |
Why?
|
| Thalamus | 13 | 2013 | 1045 | 0.900 |
Why?
|
| Internal Capsule | 5 | 2023 | 138 | 0.900 |
Why?
|
| Nerve Net | 24 | 2023 | 2290 | 0.890 |
Why?
|
| Psychiatry | 9 | 2023 | 1693 | 0.880 |
Why?
|
| Cerebrovascular Circulation | 28 | 2011 | 2727 | 0.830 |
Why?
|
| Dominance, Cerebral | 16 | 2011 | 623 | 0.820 |
Why?
|
| Limbic System | 17 | 2017 | 419 | 0.810 |
Why?
|
| Learning | 13 | 2023 | 1740 | 0.800 |
Why?
|
| Memory | 15 | 2017 | 2188 | 0.780 |
Why?
|
| Deep Brain Stimulation | 6 | 2018 | 832 | 0.770 |
Why?
|
| Conditioning, Classical | 11 | 2023 | 368 | 0.750 |
Why?
|
| Arousal | 12 | 2017 | 1166 | 0.740 |
Why?
|
| Anger | 6 | 2014 | 406 | 0.740 |
Why?
|
| Adult | 227 | 2024 | 221177 | 0.740 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 21 | 2019 | 1988 | 0.720 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 11 | 2006 | 1068 | 0.690 |
Why?
|
| Visual Perception | 9 | 2013 | 1387 | 0.690 |
Why?
|
| Humans | 383 | 2024 | 761504 | 0.660 |
Why?
|
| Attention | 16 | 2018 | 2396 | 0.660 |
Why?
|
| Psychiatric Status Rating Scales | 34 | 2021 | 6019 | 0.660 |
Why?
|
| Verbal Learning | 6 | 2017 | 463 | 0.660 |
Why?
|
| Trichotillomania | 4 | 2019 | 177 | 0.650 |
Why?
|
| Compulsive Behavior | 5 | 2013 | 117 | 0.650 |
Why?
|
| Male | 247 | 2024 | 360804 | 0.610 |
Why?
|
| Neurosciences | 4 | 2018 | 367 | 0.610 |
Why?
|
| Behavior | 4 | 2021 | 541 | 0.610 |
Why?
|
| Emotional Intelligence | 3 | 2017 | 135 | 0.600 |
Why?
|
| Internet | 5 | 2024 | 3092 | 0.590 |
Why?
|
| Female | 237 | 2024 | 392644 | 0.570 |
Why?
|
| Galvanic Skin Response | 12 | 2017 | 358 | 0.570 |
Why?
|
| Neuropsychological Tests | 39 | 2018 | 7045 | 0.570 |
Why?
|
| Stereotaxic Techniques | 8 | 2010 | 555 | 0.560 |
Why?
|
| Habituation, Psychophysiologic | 7 | 2007 | 147 | 0.560 |
Why?
|
| Bipolar Disorder | 15 | 2017 | 5092 | 0.560 |
Why?
|
| Hospitals, Psychiatric | 1 | 2018 | 321 | 0.550 |
Why?
|
| Somatosensory Cortex | 3 | 2013 | 512 | 0.520 |
Why?
|
| Functional Laterality | 26 | 2009 | 2257 | 0.520 |
Why?
|
| Depressive Disorder | 11 | 2021 | 3728 | 0.500 |
Why?
|
| Neural Pathways | 18 | 2023 | 3058 | 0.500 |
Why?
|
| Basal Ganglia | 7 | 2017 | 554 | 0.490 |
Why?
|
| Confidentiality | 1 | 2018 | 609 | 0.450 |
Why?
|
| Reaction Time | 17 | 2011 | 2082 | 0.450 |
Why?
|
| Government Regulation | 1 | 2018 | 524 | 0.440 |
Why?
|
| Panic Disorder | 8 | 2017 | 613 | 0.440 |
Why?
|
| Glutamic Acid | 3 | 2017 | 1176 | 0.440 |
Why?
|
| Reward | 8 | 2024 | 971 | 0.430 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 728 | 0.430 |
Why?
|
| Imagination | 7 | 2000 | 226 | 0.430 |
Why?
|
| Emergency Service, Hospital | 8 | 2022 | 7879 | 0.420 |
Why?
|
| Temperament | 3 | 2004 | 297 | 0.420 |
Why?
|
| Psychotherapy | 5 | 2019 | 1647 | 0.420 |
Why?
|
| Neurobiology | 2 | 2014 | 137 | 0.420 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2011 | 324 | 0.410 |
Why?
|
| Depression | 15 | 2023 | 8124 | 0.410 |
Why?
|
| Serial Learning | 3 | 2003 | 42 | 0.410 |
Why?
|
| Magnetic Resonance Spectroscopy | 9 | 2015 | 3769 | 0.410 |
Why?
|
| Affect | 8 | 2014 | 1486 | 0.400 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2012 | 67 | 0.390 |
Why?
|
| Adult Survivors of Child Abuse | 3 | 2023 | 294 | 0.390 |
Why?
|
| Glutamine | 1 | 2015 | 577 | 0.390 |
Why?
|
| Personality Inventory | 7 | 2011 | 1019 | 0.390 |
Why?
|
| Social Control, Informal | 1 | 2011 | 44 | 0.380 |
Why?
|
| Middle Aged | 124 | 2024 | 220895 | 0.380 |
Why?
|
| Expressed Emotion | 2 | 2012 | 92 | 0.380 |
Why?
|
| Photic Stimulation | 16 | 2015 | 1985 | 0.380 |
Why?
|
| Hunger | 1 | 2013 | 206 | 0.370 |
Why?
|
| Character | 1 | 2010 | 27 | 0.370 |
Why?
|
| Social Behavior | 5 | 2015 | 1135 | 0.370 |
Why?
|
| Length of Stay | 4 | 2012 | 6425 | 0.370 |
Why?
|
| Crowding | 1 | 2012 | 142 | 0.370 |
Why?
|
| Perceptual Masking | 1 | 2011 | 90 | 0.360 |
Why?
|
| Reference Values | 16 | 2010 | 4920 | 0.360 |
Why?
|
| Cycloserine | 2 | 2008 | 118 | 0.350 |
Why?
|
| Temporal Lobe | 9 | 2008 | 1695 | 0.350 |
Why?
|
| Negotiating | 1 | 2011 | 150 | 0.350 |
Why?
|
| Parietal Lobe | 6 | 2018 | 852 | 0.350 |
Why?
|
| Excitatory Amino Acid Transporter 3 | 4 | 2011 | 32 | 0.350 |
Why?
|
| Schizophrenic Psychology | 10 | 2009 | 1647 | 0.350 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2018 | 1472 | 0.350 |
Why?
|
| Positron-Emission Tomography | 12 | 2012 | 6485 | 0.340 |
Why?
|
| Young Adult | 50 | 2024 | 59243 | 0.340 |
Why?
|
| Bulimia Nervosa | 1 | 2011 | 206 | 0.340 |
Why?
|
| Cognition Disorders | 12 | 2014 | 3979 | 0.340 |
Why?
|
| Food Preferences | 1 | 2013 | 398 | 0.330 |
Why?
|
| Adolescent | 68 | 2023 | 88319 | 0.330 |
Why?
|
| Stroop Test | 1 | 2009 | 71 | 0.320 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2018 | 4063 | 0.310 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 2008 | 36 | 0.310 |
Why?
|
| Caudate Nucleus | 7 | 2010 | 389 | 0.310 |
Why?
|
| Face | 6 | 2013 | 1026 | 0.310 |
Why?
|
| Nipecotic Acids | 1 | 2008 | 36 | 0.310 |
Why?
|
| Psychosurgery | 7 | 2017 | 86 | 0.300 |
Why?
|
| Schizophrenia | 14 | 2015 | 6937 | 0.300 |
Why?
|
| Cognition | 16 | 2011 | 6990 | 0.300 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 601 | 0.300 |
Why?
|
| Nerve Tissue Proteins | 5 | 2013 | 4414 | 0.300 |
Why?
|
| Mood Disorders | 6 | 2013 | 1127 | 0.290 |
Why?
|
| Genetic Linkage | 7 | 2019 | 2341 | 0.290 |
Why?
|
| Sex Characteristics | 3 | 2024 | 2639 | 0.290 |
Why?
|
| Psychiatric Somatic Therapies | 1 | 2007 | 2 | 0.290 |
Why?
|
| Neostriatum | 4 | 2008 | 247 | 0.290 |
Why?
|
| Efficiency, Organizational | 1 | 2012 | 695 | 0.290 |
Why?
|
| Models, Neurological | 4 | 2006 | 1767 | 0.290 |
Why?
|
| Diagnostic Imaging | 5 | 2006 | 3530 | 0.290 |
Why?
|
| Wrist | 3 | 2024 | 227 | 0.280 |
Why?
|
| Psychomotor Performance | 12 | 2011 | 1881 | 0.280 |
Why?
|
| Happiness | 5 | 2005 | 170 | 0.280 |
Why?
|
| Behavior Therapy | 5 | 2008 | 879 | 0.270 |
Why?
|
| Psychological Tests | 3 | 2023 | 640 | 0.270 |
Why?
|
| Mental Health Services | 1 | 2018 | 1730 | 0.270 |
Why?
|
| Neurotic Disorders | 1 | 2006 | 77 | 0.260 |
Why?
|
| Aspartic Acid | 2 | 2017 | 576 | 0.260 |
Why?
|
| Eating | 1 | 2013 | 1539 | 0.260 |
Why?
|
| Accidents, Traffic | 5 | 2022 | 816 | 0.260 |
Why?
|
| Heart Rate | 7 | 2024 | 4195 | 0.260 |
Why?
|
| Nonverbal Communication | 3 | 2006 | 62 | 0.260 |
Why?
|
| Oxygen | 10 | 2017 | 4227 | 0.260 |
Why?
|
| Analysis of Variance | 12 | 2011 | 6228 | 0.250 |
Why?
|
| Anxiety | 8 | 2023 | 4573 | 0.250 |
Why?
|
| Regional Blood Flow | 13 | 2009 | 1496 | 0.250 |
Why?
|
| Telencephalon | 3 | 2005 | 142 | 0.240 |
Why?
|
| Rehabilitation Centers | 1 | 2006 | 246 | 0.240 |
Why?
|
| Intelligence Tests | 1 | 2006 | 503 | 0.240 |
Why?
|
| Personal Space | 2 | 2015 | 35 | 0.240 |
Why?
|
| Family | 10 | 2014 | 3194 | 0.230 |
Why?
|
| Sleep | 4 | 2023 | 4768 | 0.230 |
Why?
|
| Neurosurgical Procedures | 5 | 2010 | 2072 | 0.230 |
Why?
|
| Adaptation, Psychological | 2 | 2012 | 2629 | 0.230 |
Why?
|
| Substantia Innominata | 2 | 2003 | 23 | 0.230 |
Why?
|
| Cerebellum | 4 | 2008 | 1501 | 0.230 |
Why?
|
| Somatoform Disorders | 4 | 2006 | 423 | 0.230 |
Why?
|
| Semantics | 7 | 2009 | 601 | 0.230 |
Why?
|
| Problem Solving | 4 | 2011 | 441 | 0.220 |
Why?
|
| Executive Function | 7 | 2017 | 1389 | 0.220 |
Why?
|
| Severity of Illness Index | 24 | 2018 | 15842 | 0.220 |
Why?
|
| Iron Overload | 3 | 2017 | 239 | 0.220 |
Why?
|
| Anxiety, Separation | 2 | 2015 | 86 | 0.220 |
Why?
|
| Fluvoxamine | 2 | 2002 | 78 | 0.220 |
Why?
|
| Color Perception | 2 | 2010 | 213 | 0.220 |
Why?
|
| Combat Disorders | 3 | 2011 | 301 | 0.220 |
Why?
|
| Motor Vehicles | 5 | 2023 | 282 | 0.210 |
Why?
|
| Menstrual Cycle | 1 | 2006 | 539 | 0.210 |
Why?
|
| Organ Size | 6 | 2017 | 2254 | 0.210 |
Why?
|
| Psychometrics | 8 | 2021 | 3065 | 0.210 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2023 | 2400 | 0.200 |
Why?
|
| Meditation | 3 | 2011 | 251 | 0.200 |
Why?
|
| Verbal Behavior | 7 | 2008 | 335 | 0.200 |
Why?
|
| Veterans | 7 | 2022 | 2647 | 0.200 |
Why?
|
| Substance-Related Disorders | 6 | 2023 | 4420 | 0.200 |
Why?
|
| Oxygen Radioisotopes | 4 | 1999 | 75 | 0.200 |
Why?
|
| Body Weight | 1 | 2013 | 4618 | 0.200 |
Why?
|
| Aggression | 3 | 2012 | 750 | 0.200 |
Why?
|
| Space Perception | 1 | 2005 | 465 | 0.200 |
Why?
|
| Electroconvulsive Therapy | 1 | 2007 | 500 | 0.190 |
Why?
|
| Child Abuse | 3 | 2023 | 1077 | 0.190 |
Why?
|
| Systems Theory | 1 | 2021 | 57 | 0.190 |
Why?
|
| Dreams | 1 | 2022 | 146 | 0.190 |
Why?
|
| Neural Inhibition | 1 | 2005 | 590 | 0.190 |
Why?
|
| Vietnam Conflict | 2 | 2011 | 100 | 0.190 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2007 | 952 | 0.180 |
Why?
|
| Perception | 4 | 2015 | 1197 | 0.180 |
Why?
|
| Race Relations | 1 | 2000 | 37 | 0.180 |
Why?
|
| Electronic Health Records | 1 | 2018 | 4811 | 0.180 |
Why?
|
| Attitude of Health Personnel | 2 | 2012 | 3889 | 0.180 |
Why?
|
| Wounds and Injuries | 4 | 2021 | 2491 | 0.180 |
Why?
|
| Psychological Theory | 1 | 2021 | 175 | 0.180 |
Why?
|
| Residential Treatment | 1 | 2021 | 111 | 0.180 |
Why?
|
| Dissociative Disorders | 1 | 2022 | 234 | 0.170 |
Why?
|
| Interpersonal Relations | 3 | 2014 | 1436 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 6 | 2007 | 3708 | 0.170 |
Why?
|
| Guilt | 1 | 2000 | 96 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2014 | 15936 | 0.170 |
Why?
|
| Resilience, Psychological | 2 | 2024 | 788 | 0.170 |
Why?
|
| Brain Injuries | 5 | 2010 | 2053 | 0.170 |
Why?
|
| Evoked Potentials, Visual | 1 | 2002 | 417 | 0.170 |
Why?
|
| Anorexia Nervosa | 3 | 2006 | 1361 | 0.170 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2019 | 50 | 0.170 |
Why?
|
| Libido | 1 | 1999 | 119 | 0.160 |
Why?
|
| Dependent Personality Disorder | 2 | 2015 | 13 | 0.150 |
Why?
|
| Antidepressive Agents | 2 | 2009 | 2897 | 0.150 |
Why?
|
| Radiosurgery | 3 | 2017 | 1342 | 0.150 |
Why?
|
| Models, Psychological | 3 | 2008 | 828 | 0.150 |
Why?
|
| Treatment Outcome | 26 | 2024 | 64680 | 0.150 |
Why?
|
| Privacy | 2 | 2022 | 233 | 0.150 |
Why?
|
| Language | 4 | 2006 | 1540 | 0.150 |
Why?
|
| Arthritis, Gouty | 1 | 2018 | 28 | 0.150 |
Why?
|
| Decision Making | 5 | 2017 | 3929 | 0.150 |
Why?
|
| Massachusetts | 4 | 2014 | 8830 | 0.150 |
Why?
|
| Agoraphobia | 2 | 2015 | 177 | 0.150 |
Why?
|
| Compulsive Personality Disorder | 2 | 2015 | 48 | 0.150 |
Why?
|
| Sleep Deprivation | 2 | 2014 | 846 | 0.150 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2018 | 303 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2014 | 17904 | 0.150 |
Why?
|
| Neurosurgery | 1 | 2004 | 679 | 0.140 |
Why?
|
| Telemetry | 1 | 2018 | 199 | 0.140 |
Why?
|
| Statistics as Topic | 4 | 2017 | 2358 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2008 | 287 | 0.140 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2019 | 2790 | 0.140 |
Why?
|
| Cannabis | 1 | 2023 | 441 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2004 | 1474 | 0.140 |
Why?
|
| Oxygen Consumption | 4 | 2011 | 1866 | 0.140 |
Why?
|
| DDT | 1 | 2016 | 32 | 0.140 |
Why?
|
| Self Report | 5 | 2023 | 3724 | 0.140 |
Why?
|
| Prospective Studies | 16 | 2024 | 54425 | 0.140 |
Why?
|
| Animals | 29 | 2024 | 168459 | 0.140 |
Why?
|
| New England | 2 | 2012 | 1054 | 0.130 |
Why?
|
| Case-Control Studies | 19 | 2017 | 22176 | 0.130 |
Why?
|
| History, 21st Century | 2 | 2017 | 1567 | 0.130 |
Why?
|
| Genitalia, Male | 1 | 2016 | 87 | 0.130 |
Why?
|
| Delphi Technique | 1 | 2020 | 846 | 0.130 |
Why?
|
| Cholecystokinin | 1 | 1996 | 117 | 0.130 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 1787 | 0.130 |
Why?
|
| Regression Analysis | 10 | 2012 | 6343 | 0.130 |
Why?
|
| Ablation Techniques | 2 | 2010 | 248 | 0.130 |
Why?
|
| Psychophysics | 2 | 2007 | 292 | 0.130 |
Why?
|
| Fluorodeoxyglucose F18 | 5 | 2012 | 2010 | 0.130 |
Why?
|
| Cyclohexanols | 1 | 1996 | 126 | 0.130 |
Why?
|
| Hemochromatosis | 1 | 2017 | 174 | 0.130 |
Why?
|
| Social Isolation | 2 | 2009 | 364 | 0.130 |
Why?
|
| Genitalia, Female | 1 | 2016 | 147 | 0.120 |
Why?
|
| Time Factors | 15 | 2018 | 39967 | 0.120 |
Why?
|
| Cerebellar Cortex | 2 | 2006 | 107 | 0.120 |
Why?
|
| Adaptation, Physiological | 2 | 2014 | 1301 | 0.120 |
Why?
|
| Sex Factors | 12 | 2010 | 10552 | 0.120 |
Why?
|
| Remote Consultation | 1 | 2017 | 237 | 0.120 |
Why?
|
| Checklist | 1 | 2022 | 827 | 0.120 |
Why?
|
| Residence Characteristics | 1 | 2024 | 2093 | 0.120 |
Why?
|
| Internationality | 1 | 2020 | 1001 | 0.120 |
Why?
|
| Orientation | 3 | 2010 | 321 | 0.120 |
Why?
|
| Review Literature as Topic | 2 | 2023 | 348 | 0.120 |
Why?
|
| Cues | 2 | 2013 | 875 | 0.120 |
Why?
|
| Saccades | 4 | 2007 | 234 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 5440 | 0.120 |
Why?
|
| Glucose | 4 | 2012 | 4346 | 0.120 |
Why?
|
| Memory, Short-Term | 4 | 2014 | 982 | 0.120 |
Why?
|
| Plant Roots | 1 | 2014 | 117 | 0.120 |
Why?
|
| Cohort Studies | 14 | 2021 | 41487 | 0.110 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2014 | 211 | 0.110 |
Why?
|
| Optic Nerve | 1 | 2017 | 572 | 0.110 |
Why?
|
| Hypothalamus | 2 | 2024 | 999 | 0.110 |
Why?
|
| Siderosis | 1 | 2014 | 103 | 0.110 |
Why?
|
| 14-3-3 Proteins | 1 | 2014 | 220 | 0.110 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2013 | 39 | 0.110 |
Why?
|
| Food | 2 | 2013 | 774 | 0.110 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 261 | 0.110 |
Why?
|
| Comorbidity | 18 | 2019 | 10508 | 0.110 |
Why?
|
| Habenula | 1 | 2013 | 37 | 0.110 |
Why?
|
| Pain | 3 | 2023 | 5073 | 0.110 |
Why?
|
| Recruitment, Neurophysiological | 2 | 2006 | 33 | 0.110 |
Why?
|
| Health Status | 2 | 2008 | 4077 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2002 | 4124 | 0.110 |
Why?
|
| Psychotherapy, Group | 1 | 2016 | 412 | 0.110 |
Why?
|
| Observer Variation | 5 | 2008 | 2606 | 0.100 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 2 | 2024 | 108 | 0.100 |
Why?
|
| Longitudinal Studies | 7 | 2024 | 14605 | 0.100 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 1996 | 489 | 0.100 |
Why?
|
| Electric Stimulation | 3 | 2006 | 1736 | 0.100 |
Why?
|
| Affective Symptoms | 1 | 2015 | 417 | 0.100 |
Why?
|
| Multiple Sclerosis | 3 | 2017 | 3220 | 0.100 |
Why?
|
| Task Performance and Analysis | 4 | 2014 | 763 | 0.100 |
Why?
|
| Research Design | 5 | 2023 | 6180 | 0.100 |
Why?
|
| Obsessive Behavior | 1 | 2012 | 51 | 0.100 |
Why?
|
| Reading | 1 | 1996 | 529 | 0.100 |
Why?
|
| Diseases in Twins | 2 | 2011 | 446 | 0.100 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2009 | 701 | 0.100 |
Why?
|
| Hospital Departments | 1 | 2012 | 134 | 0.100 |
Why?
|
| Aged | 38 | 2023 | 169289 | 0.100 |
Why?
|
| Child | 26 | 2017 | 80153 | 0.100 |
Why?
|
| Child of Impaired Parents | 1 | 2015 | 460 | 0.100 |
Why?
|
| Spiders | 1 | 2010 | 11 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2006 | 6391 | 0.090 |
Why?
|
| Life Change Events | 5 | 2021 | 952 | 0.090 |
Why?
|
| Fatty Liver | 2 | 2014 | 790 | 0.090 |
Why?
|
| Snakes | 1 | 2010 | 27 | 0.090 |
Why?
|
| Games, Experimental | 1 | 2010 | 32 | 0.090 |
Why?
|
| Ethics Committees, Research | 2 | 2023 | 196 | 0.090 |
Why?
|
| Arabidopsis | 1 | 2014 | 465 | 0.090 |
Why?
|
| Gambling | 1 | 2014 | 258 | 0.090 |
Why?
|
| Blood Pressure | 3 | 2024 | 8481 | 0.090 |
Why?
|
| Appetite | 1 | 2013 | 247 | 0.090 |
Why?
|
| Family Health | 4 | 2014 | 1257 | 0.090 |
Why?
|
| Religion and Medicine | 1 | 2012 | 161 | 0.090 |
Why?
|
| Research Personnel | 2 | 2023 | 588 | 0.090 |
Why?
|
| Anticipation, Psychological | 1 | 2011 | 85 | 0.090 |
Why?
|
| Huntington Disease | 1 | 1997 | 1144 | 0.090 |
Why?
|
| Postoperative Nausea and Vomiting | 2 | 2002 | 128 | 0.090 |
Why?
|
| Telemedicine | 2 | 2019 | 3051 | 0.090 |
Why?
|
| Medical Audit | 1 | 2012 | 453 | 0.090 |
Why?
|
| Carbon Dioxide | 2 | 1999 | 1147 | 0.090 |
Why?
|
| Patient Preference | 1 | 2018 | 924 | 0.090 |
Why?
|
| Diagnosis, Differential | 11 | 2018 | 12974 | 0.090 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2013 | 543 | 0.090 |
Why?
|
| Form Perception | 3 | 2002 | 175 | 0.090 |
Why?
|
| Genes, Homeobox | 1 | 2011 | 285 | 0.090 |
Why?
|
| Consensus | 1 | 2020 | 3123 | 0.090 |
Why?
|
| Mental Processes | 3 | 2001 | 244 | 0.090 |
Why?
|
| Reversal Learning | 1 | 2010 | 57 | 0.090 |
Why?
|
| Pancreas | 1 | 2017 | 1691 | 0.090 |
Why?
|
| Rest | 2 | 2017 | 918 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2018 | 1126 | 0.080 |
Why?
|
| Radiography | 4 | 2013 | 6965 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3575 | 0.080 |
Why?
|
| Stress, Psychological | 4 | 2015 | 4481 | 0.080 |
Why?
|
| Protons | 1 | 2015 | 1116 | 0.080 |
Why?
|
| Knee Joint | 1 | 2018 | 1676 | 0.080 |
Why?
|
| Hot Flashes | 1 | 2012 | 330 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2017 | 2767 | 0.080 |
Why?
|
| Generalization, Stimulus | 1 | 2009 | 13 | 0.080 |
Why?
|
| Psychopathology | 2 | 2023 | 432 | 0.080 |
Why?
|
| Visual Cortex | 3 | 2008 | 1107 | 0.080 |
Why?
|
| Follow-Up Studies | 13 | 2015 | 39106 | 0.080 |
Why?
|
| Rodentia | 1 | 2010 | 262 | 0.080 |
Why?
|
| Hygiene | 1 | 2009 | 94 | 0.080 |
Why?
|
| Maternal Exposure | 1 | 2016 | 1067 | 0.080 |
Why?
|
| Survivors | 3 | 2024 | 2371 | 0.080 |
Why?
|
| Factor Analysis, Statistical | 5 | 2015 | 999 | 0.080 |
Why?
|
| Pedigree | 5 | 2009 | 4542 | 0.080 |
Why?
|
| Dopamine Antagonists | 1 | 2009 | 288 | 0.080 |
Why?
|
| Child Abuse, Sexual | 3 | 1999 | 403 | 0.080 |
Why?
|
| Hospitals, Community | 1 | 2011 | 365 | 0.080 |
Why?
|
| Vietnam | 3 | 2007 | 409 | 0.080 |
Why?
|
| Animal Experimentation | 1 | 2008 | 46 | 0.080 |
Why?
|
| Sickness Impact Profile | 3 | 2012 | 299 | 0.080 |
Why?
|
| Trauma Severity Indices | 2 | 2021 | 478 | 0.070 |
Why?
|
| Anisotropy | 2 | 2023 | 1283 | 0.070 |
Why?
|
| Trust | 1 | 2013 | 530 | 0.070 |
Why?
|
| Age of Onset | 8 | 2009 | 3305 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 2164 | 0.070 |
Why?
|
| Genes, Immediate-Early | 1 | 2007 | 102 | 0.070 |
Why?
|
| Wound Healing | 2 | 2009 | 2805 | 0.070 |
Why?
|
| Association Learning | 4 | 2010 | 221 | 0.070 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2007 | 415 | 0.070 |
Why?
|
| Personality Disorders | 3 | 2015 | 722 | 0.070 |
Why?
|
| Sibling Relations | 1 | 2006 | 46 | 0.070 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2013 | 1141 | 0.070 |
Why?
|
| Radiopharmaceuticals | 3 | 2012 | 2651 | 0.070 |
Why?
|
| Evoked Potentials | 2 | 2012 | 1038 | 0.070 |
Why?
|
| Placebos | 3 | 2008 | 1667 | 0.070 |
Why?
|
| Anthropometry | 2 | 2016 | 1349 | 0.070 |
Why?
|
| Hemoglobins | 3 | 2008 | 1525 | 0.070 |
Why?
|
| Energy Intake | 2 | 2013 | 2134 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2018 | 1404 | 0.070 |
Why?
|
| Nucleus Accumbens | 1 | 2009 | 366 | 0.070 |
Why?
|
| Implosive Therapy | 1 | 2008 | 125 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2015 | 1298 | 0.070 |
Why?
|
| Twins | 1 | 2008 | 339 | 0.070 |
Why?
|
| Antipsychotic Agents | 5 | 2007 | 3067 | 0.070 |
Why?
|
| Prognosis | 7 | 2021 | 29625 | 0.070 |
Why?
|
| Citalopram | 1 | 2009 | 402 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 1992 | 1132 | 0.070 |
Why?
|
| Radionuclide Imaging | 3 | 2013 | 1972 | 0.060 |
Why?
|
| Mental Health | 2 | 2021 | 3250 | 0.060 |
Why?
|
| Progesterone | 1 | 2010 | 742 | 0.060 |
Why?
|
| Brain Diseases | 1 | 1995 | 1545 | 0.060 |
Why?
|
| Siblings | 2 | 2006 | 825 | 0.060 |
Why?
|
| Forecasting | 3 | 2004 | 2928 | 0.060 |
Why?
|
| Terrorism | 1 | 2008 | 211 | 0.060 |
Why?
|
| Psychophysiology | 2 | 2021 | 136 | 0.060 |
Why?
|
| ROC Curve | 3 | 2021 | 3579 | 0.060 |
Why?
|
| Monoamine Oxidase Inhibitors | 2 | 1997 | 156 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 10209 | 0.060 |
Why?
|
| Atrophy | 3 | 2005 | 1633 | 0.060 |
Why?
|
| Oxytocin | 1 | 2009 | 402 | 0.060 |
Why?
|
| Prevalence | 5 | 2020 | 15732 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2008 | 740 | 0.060 |
Why?
|
| Neuroradiography | 1 | 2005 | 71 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2018 | 5972 | 0.060 |
Why?
|
| Patient Transfer | 1 | 2012 | 794 | 0.060 |
Why?
|
| Reproducibility of Results | 10 | 2015 | 20098 | 0.060 |
Why?
|
| Wechsler Scales | 1 | 2005 | 257 | 0.060 |
Why?
|
| Combined Modality Therapy | 4 | 2009 | 8529 | 0.060 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 58976 | 0.060 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 293 | 0.060 |
Why?
|
| Vagus Nerve | 1 | 2007 | 458 | 0.060 |
Why?
|
| Chromosomes, Human | 1 | 2006 | 441 | 0.060 |
Why?
|
| Pilot Projects | 4 | 2017 | 8631 | 0.060 |
Why?
|
| Cholinergic Fibers | 1 | 1984 | 69 | 0.060 |
Why?
|
| Oximes | 1 | 2005 | 303 | 0.060 |
Why?
|
| Occipital Lobe | 1 | 2006 | 374 | 0.060 |
Why?
|
| Auditory Cortex | 1 | 2008 | 363 | 0.060 |
Why?
|
| Rehabilitation | 1 | 2005 | 130 | 0.060 |
Why?
|
| Delusions | 1 | 2006 | 298 | 0.060 |
Why?
|
| Benzazepines | 1 | 2006 | 310 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 2518 | 0.060 |
Why?
|
| Rats | 8 | 2009 | 23742 | 0.060 |
Why?
|
| Antihypertensive Agents | 3 | 1997 | 2024 | 0.060 |
Why?
|
| Liver | 3 | 2017 | 7529 | 0.060 |
Why?
|
| Genetic Markers | 4 | 2013 | 2601 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 1997 | 2877 | 0.050 |
Why?
|
| Parahippocampal Gyrus | 1 | 2004 | 115 | 0.050 |
Why?
|
| Clonazepam | 2 | 1994 | 135 | 0.050 |
Why?
|
| Neuronal Plasticity | 3 | 2008 | 1436 | 0.050 |
Why?
|
| Polymorphism, Genetic | 2 | 2012 | 4243 | 0.050 |
Why?
|
| Gene Frequency | 4 | 2013 | 3606 | 0.050 |
Why?
|
| Auditory Perception | 1 | 2008 | 583 | 0.050 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 15266 | 0.050 |
Why?
|
| Awareness | 3 | 2011 | 648 | 0.050 |
Why?
|
| Motivation | 1 | 2013 | 2006 | 0.050 |
Why?
|
| Self Mutilation | 2 | 2001 | 57 | 0.050 |
Why?
|
| Biological Availability | 1 | 2023 | 390 | 0.050 |
Why?
|
| Haplotypes | 4 | 2011 | 2713 | 0.050 |
Why?
|
| Age Factors | 9 | 2012 | 18395 | 0.050 |
Why?
|
| Interviews as Topic | 2 | 2007 | 2696 | 0.050 |
Why?
|
| Estradiol | 1 | 2010 | 1937 | 0.050 |
Why?
|
| Phenotype | 9 | 2014 | 16591 | 0.050 |
Why?
|
| Genotype | 7 | 2012 | 12990 | 0.050 |
Why?
|
| United States | 8 | 2021 | 72334 | 0.050 |
Why?
|
| Syndrome | 2 | 2008 | 3267 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2008 | 894 | 0.050 |
Why?
|
| Double-Blind Method | 4 | 2008 | 12341 | 0.050 |
Why?
|
| Postoperative Complications | 3 | 2002 | 15631 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2006 | 2707 | 0.050 |
Why?
|
| Neurosecretory Systems | 1 | 2004 | 223 | 0.050 |
Why?
|
| Entorhinal Cortex | 1 | 2024 | 287 | 0.050 |
Why?
|
| Discrimination Learning | 1 | 1984 | 278 | 0.050 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 26125 | 0.050 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 1994 | 432 | 0.050 |
Why?
|
| Neurites | 1 | 2024 | 391 | 0.050 |
Why?
|
| Exploratory Behavior | 1 | 2003 | 279 | 0.050 |
Why?
|
| Cocaine | 1 | 2007 | 958 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2021 | 51 | 0.050 |
Why?
|
| Neurons | 3 | 2013 | 9463 | 0.050 |
Why?
|
| Suicidal Ideation | 1 | 2012 | 1447 | 0.050 |
Why?
|
| Evoked Potentials, Motor | 1 | 2004 | 464 | 0.050 |
Why?
|
| Genome-Wide Association Study | 4 | 2014 | 12690 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2008 | 1475 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2005 | 732 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2016 | 4486 | 0.050 |
Why?
|
| Acoustic Stimulation | 2 | 2008 | 1235 | 0.050 |
Why?
|
| Word Association Tests | 1 | 2001 | 52 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2009 | 1878 | 0.050 |
Why?
|
| Globus Pallidus | 2 | 1999 | 250 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2007 | 1136 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 1 | 2004 | 552 | 0.040 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2000 | 109 | 0.040 |
Why?
|
| Risk Factors | 10 | 2023 | 74206 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 2759 | 0.040 |
Why?
|
| Basal Ganglia Diseases | 2 | 1997 | 145 | 0.040 |
Why?
|
| Systems Analysis | 1 | 2021 | 169 | 0.040 |
Why?
|
| Postoperative Period | 2 | 2002 | 1813 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 20570 | 0.040 |
Why?
|
| Habits | 1 | 2000 | 147 | 0.040 |
Why?
|
| Communication | 1 | 2014 | 3873 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2012 | 2498 | 0.040 |
Why?
|
| Neurology | 1 | 2007 | 780 | 0.040 |
Why?
|
| Brain Chemistry | 2 | 2007 | 960 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2004 | 751 | 0.040 |
Why?
|
| Hydrocortisone | 2 | 2004 | 1819 | 0.040 |
Why?
|
| Pursuit, Smooth | 1 | 1998 | 38 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2008 | 2421 | 0.040 |
Why?
|
| Technology | 1 | 2021 | 292 | 0.040 |
Why?
|
| Teaching | 1 | 2006 | 1170 | 0.040 |
Why?
|
| Alleles | 1 | 2010 | 6863 | 0.040 |
Why?
|
| Echo-Planar Imaging | 1 | 2003 | 663 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 2169 | 0.040 |
Why?
|
| Remission Induction | 1 | 2004 | 2396 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2008 | 2180 | 0.040 |
Why?
|
| Sensation | 1 | 2000 | 337 | 0.040 |
Why?
|
| Phenelzine | 1 | 1997 | 28 | 0.040 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 2578 | 0.040 |
Why?
|
| Physical Exertion | 1 | 2001 | 667 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2011 | 361 | 0.040 |
Why?
|
| Artifacts | 2 | 1996 | 1911 | 0.040 |
Why?
|
| Twins, Monozygotic | 2 | 2011 | 470 | 0.040 |
Why?
|
| Motor Activity | 1 | 2007 | 2715 | 0.040 |
Why?
|
| Patient Selection | 2 | 2003 | 4244 | 0.040 |
Why?
|
| Motor Cortex | 2 | 2011 | 1006 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 14666 | 0.040 |
Why?
|
| Fluoxetine | 2 | 1999 | 733 | 0.040 |
Why?
|
| Physician's Role | 1 | 2004 | 917 | 0.040 |
Why?
|
| Online Systems | 1 | 1998 | 182 | 0.030 |
Why?
|
| Anesthetics, Inhalation | 1 | 2002 | 574 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2001 | 1371 | 0.030 |
Why?
|
| Feces | 1 | 2023 | 1497 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2011 | 638 | 0.030 |
Why?
|
| Touch | 2 | 2000 | 313 | 0.030 |
Why?
|
| Aging | 5 | 2007 | 8708 | 0.030 |
Why?
|
| Meprobamate | 1 | 1996 | 4 | 0.030 |
Why?
|
| Diet, Protein-Restricted | 1 | 1997 | 73 | 0.030 |
Why?
|
| Hypertension, Renal | 1 | 1996 | 135 | 0.030 |
Why?
|
| Pest Control | 1 | 2016 | 29 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1132 | 0.030 |
Why?
|
| Serotonin Antagonists | 1 | 1996 | 145 | 0.030 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2016 | 86 | 0.030 |
Why?
|
| Linear Models | 2 | 2004 | 5871 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1996 | 208 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2007 | 322 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 1998 | 3357 | 0.030 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 1995 | 61 | 0.030 |
Why?
|
| Occupational Diseases | 1 | 2004 | 1490 | 0.030 |
Why?
|
| Oligoclonal Bands | 1 | 2015 | 17 | 0.030 |
Why?
|
| Informed Consent | 1 | 2022 | 1008 | 0.030 |
Why?
|
| Biomedical Research | 2 | 2008 | 3429 | 0.030 |
Why?
|
| Amino Acids, Cyclic | 1 | 2014 | 2 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 3 | 2011 | 2691 | 0.030 |
Why?
|
| Chromosome Mapping | 3 | 2008 | 4615 | 0.030 |
Why?
|
| Iowa | 1 | 2014 | 104 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2023 | 1403 | 0.030 |
Why?
|
| Sympatholytics | 1 | 1994 | 82 | 0.030 |
Why?
|
| Austria | 1 | 2015 | 207 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2017 | 351 | 0.030 |
Why?
|
| Cooperative Behavior | 2 | 2014 | 1505 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2006 | 2882 | 0.030 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2002 | 1007 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 2014 | 138 | 0.030 |
Why?
|
| Fenfluramine | 1 | 1994 | 58 | 0.030 |
Why?
|
| Neocortex | 1 | 1998 | 417 | 0.030 |
Why?
|
| Mannitol | 1 | 2014 | 180 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 1999 | 1035 | 0.030 |
Why?
|
| Tic Disorders | 2 | 2008 | 136 | 0.030 |
Why?
|
| Testosterone | 1 | 2004 | 2472 | 0.030 |
Why?
|
| Clonidine | 1 | 1994 | 169 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 3205 | 0.030 |
Why?
|
| Buspirone | 1 | 1994 | 81 | 0.030 |
Why?
|
| Anti-Anxiety Agents | 1 | 1996 | 397 | 0.030 |
Why?
|
| Hyperostosis Frontalis Interna | 1 | 1973 | 3 | 0.030 |
Why?
|
| Ambulatory Care | 4 | 2005 | 2775 | 0.030 |
Why?
|
| Social Environment | 2 | 2009 | 1020 | 0.030 |
Why?
|
| Dopamine | 2 | 2014 | 1607 | 0.030 |
Why?
|
| Linkage Disequilibrium | 2 | 2009 | 1998 | 0.030 |
Why?
|
| Neuropharmacology | 1 | 1993 | 20 | 0.030 |
Why?
|
| Genome, Human | 1 | 2006 | 4425 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2006 | 8002 | 0.030 |
Why?
|
| Arabidopsis Proteins | 1 | 2014 | 264 | 0.030 |
Why?
|
| Chronic Disease | 5 | 2008 | 9318 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2001 | 2242 | 0.030 |
Why?
|
| Hospitals, Voluntary | 1 | 2012 | 39 | 0.030 |
Why?
|
| Logistic Models | 4 | 2015 | 13255 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 818 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2009 | 8181 | 0.030 |
Why?
|
| Electrodes, Implanted | 2 | 2008 | 840 | 0.030 |
Why?
|
| Endonucleases | 1 | 2015 | 371 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2004 | 618 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2012 | 107 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 2 | 1991 | 461 | 0.020 |
Why?
|
| Hypertension | 2 | 1997 | 8540 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2014 | 656 | 0.020 |
Why?
|
| Biopsy | 2 | 2015 | 6766 | 0.020 |
Why?
|
| Contingent Negative Variation | 1 | 2011 | 36 | 0.020 |
Why?
|
| Synaptic Membranes | 1 | 1991 | 89 | 0.020 |
Why?
|
| Eye Movements | 1 | 1995 | 511 | 0.020 |
Why?
|
| Carbon Radioisotopes | 2 | 2006 | 561 | 0.020 |
Why?
|
| Defibrillators, Implantable | 1 | 2001 | 1490 | 0.020 |
Why?
|
| Disease Progression | 3 | 2018 | 13506 | 0.020 |
Why?
|
| Rats, Inbred Strains | 3 | 1991 | 2088 | 0.020 |
Why?
|
| Motor Skills | 2 | 2006 | 521 | 0.020 |
Why?
|
| Robotics | 1 | 1998 | 819 | 0.020 |
Why?
|
| South Africa | 1 | 2016 | 1842 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2014 | 694 | 0.020 |
Why?
|
| Body Temperature Regulation | 1 | 2012 | 292 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2001 | 4159 | 0.020 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1992 | 223 | 0.020 |
Why?
|
| Motion Perception | 1 | 2014 | 374 | 0.020 |
Why?
|
| Military Personnel | 1 | 2019 | 1246 | 0.020 |
Why?
|
| Genomics | 1 | 2006 | 5821 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 2017 | 1189 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2004 | 10766 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2023 | 26198 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2010 | 329 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 2576 | 0.020 |
Why?
|
| Inpatients | 1 | 2021 | 2548 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2014 | 1699 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 11903 | 0.020 |
Why?
|
| Drug Administration Schedule | 3 | 2004 | 4853 | 0.020 |
Why?
|
| Phenytoin | 1 | 1990 | 190 | 0.020 |
Why?
|
| Demography | 1 | 2014 | 1648 | 0.020 |
Why?
|
| Thiazoles | 1 | 1996 | 1517 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1995 | 1440 | 0.020 |
Why?
|
| Child, Preschool | 6 | 2015 | 42230 | 0.020 |
Why?
|
| Electroshock | 1 | 2009 | 121 | 0.020 |
Why?
|
| Algorithms | 5 | 2014 | 14031 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3702 | 0.020 |
Why?
|
| Patient Admission | 2 | 2012 | 1367 | 0.020 |
Why?
|
| Animal Rights | 1 | 2008 | 10 | 0.020 |
Why?
|
| Psychotropic Drugs | 2 | 1992 | 888 | 0.020 |
Why?
|
| Valproic Acid | 1 | 1991 | 443 | 0.020 |
Why?
|
| Neurologic Examination | 3 | 1996 | 916 | 0.020 |
Why?
|
| Language Tests | 1 | 2008 | 190 | 0.020 |
Why?
|
| Thinking | 1 | 2011 | 320 | 0.020 |
Why?
|
| Nuclear Family | 1 | 2009 | 311 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2006 | 18252 | 0.020 |
Why?
|
| Iron | 1 | 2017 | 1793 | 0.020 |
Why?
|
| Hormones | 1 | 2012 | 869 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 1996 | 1179 | 0.020 |
Why?
|
| Environment | 1 | 2014 | 1123 | 0.020 |
Why?
|
| Recovery of Function | 2 | 2008 | 2979 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2011 | 809 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2004 | 6310 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2017 | 80636 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2000 | 3188 | 0.020 |
Why?
|
| Feedback, Psychological | 1 | 2007 | 96 | 0.020 |
Why?
|
| Parotitis | 1 | 1967 | 28 | 0.020 |
Why?
|
| Acute Disease | 1 | 2018 | 7237 | 0.020 |
Why?
|
| Magnetoencephalography | 1 | 2011 | 636 | 0.020 |
Why?
|
| Research | 1 | 1996 | 1982 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2021 | 23995 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2014 | 1403 | 0.020 |
Why?
|
| Crime | 1 | 2008 | 202 | 0.020 |
Why?
|
| Intention | 1 | 2010 | 347 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1994 | 1530 | 0.020 |
Why?
|
| Ethics, Research | 1 | 2008 | 176 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2008 | 650 | 0.020 |
Why?
|
| Wakefulness | 2 | 2009 | 1265 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2008 | 535 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1999 | 4936 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2007 | 284 | 0.020 |
Why?
|
| Blinking | 1 | 2007 | 133 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 1336 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2008 | 352 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3808 | 0.020 |
Why?
|
| Self-Injurious Behavior | 1 | 2012 | 566 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2008 | 784 | 0.020 |
Why?
|
| Synaptic Transmission | 2 | 2000 | 1173 | 0.020 |
Why?
|
| Piperazines | 1 | 1996 | 2523 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1997 | 2091 | 0.020 |
Why?
|
| Oxyhemoglobins | 1 | 2006 | 211 | 0.020 |
Why?
|
| Lod Score | 1 | 2006 | 600 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2012 | 1349 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2001 | 12953 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2006 | 310 | 0.020 |
Why?
|
| Primates | 1 | 2008 | 523 | 0.020 |
Why?
|
| Sensation Disorders | 2 | 1997 | 160 | 0.020 |
Why?
|
| Corpus Callosum | 2 | 2003 | 751 | 0.020 |
Why?
|
| Desensitization, Psychologic | 1 | 2004 | 27 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2006 | 367 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2008 | 943 | 0.020 |
Why?
|
| Tics | 1 | 2005 | 74 | 0.020 |
Why?
|
| Noise | 1 | 2007 | 290 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2013 | 1664 | 0.010 |
Why?
|
| N-Methylscopolamine | 1 | 1984 | 4 | 0.010 |
Why?
|
| Arecoline | 1 | 1984 | 9 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2008 | 1045 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2009 | 2281 | 0.010 |
Why?
|
| Scopolamine Derivatives | 1 | 1984 | 24 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2009 | 937 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1996 | 2471 | 0.010 |
Why?
|
| Menopause | 1 | 2012 | 1646 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 2116 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2014 | 3442 | 0.010 |
Why?
|
| Employment | 1 | 2010 | 1118 | 0.010 |
Why?
|
| Scopolamine | 1 | 1984 | 93 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 882 | 0.010 |
Why?
|
| Fingers | 1 | 2006 | 507 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 4544 | 0.010 |
Why?
|
| Software | 2 | 2008 | 4434 | 0.010 |
Why?
|
| Personality | 1 | 2006 | 554 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2008 | 1596 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10090 | 0.010 |
Why?
|
| Probability | 2 | 1999 | 2477 | 0.010 |
Why?
|
| Electromyography | 1 | 2007 | 1394 | 0.010 |
Why?
|
| Magnetics | 1 | 2004 | 599 | 0.010 |
Why?
|
| Species Specificity | 1 | 2006 | 2414 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2008 | 1742 | 0.010 |
Why?
|
| Vitamin D | 1 | 2015 | 3303 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3688 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 3416 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 4111 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2012 | 1940 | 0.010 |
Why?
|
| Infant | 2 | 2016 | 36192 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2005 | 710 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4575 | 0.010 |
Why?
|
| Quality of Life | 3 | 2012 | 13367 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5796 | 0.010 |
Why?
|
| Delirium | 1 | 1992 | 1668 | 0.010 |
Why?
|
| Vocabulary | 1 | 2000 | 165 | 0.010 |
Why?
|
| Clomipramine | 1 | 1999 | 54 | 0.010 |
Why?
|
| Movement | 1 | 2006 | 1478 | 0.010 |
Why?
|
| Volition | 1 | 1999 | 62 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3778 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4740 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2008 | 2025 | 0.010 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 1999 | 186 | 0.010 |
Why?
|
| Electric Stimulation Therapy | 1 | 2004 | 628 | 0.010 |
Why?
|
| Pregnancy | 3 | 2016 | 29874 | 0.010 |
Why?
|
| Parents | 1 | 2012 | 3563 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2008 | 3550 | 0.010 |
Why?
|
| Equipment Failure | 1 | 2001 | 578 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1984 | 2678 | 0.010 |
Why?
|
| Urinary Incontinence | 1 | 2002 | 489 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 2726 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 7827 | 0.010 |
Why?
|
| Putamen | 1 | 1997 | 292 | 0.010 |
Why?
|
| Burns | 1 | 2007 | 1882 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 8465 | 0.010 |
Why?
|
| Behavioral Symptoms | 1 | 1997 | 186 | 0.010 |
Why?
|
| Placebo Effect | 1 | 1999 | 518 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2012 | 7856 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2010 | 6567 | 0.010 |
Why?
|
| Reoperation | 2 | 1996 | 4303 | 0.010 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 1997 | 269 | 0.010 |
Why?
|
| Pyrimidinones | 1 | 1996 | 385 | 0.010 |
Why?
|
| Proteinuria | 1 | 1997 | 607 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1996 | 665 | 0.010 |
Why?
|
| Visual Pathways | 1 | 1996 | 551 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 12059 | 0.010 |
Why?
|
| Safety | 1 | 1997 | 1150 | 0.010 |
Why?
|
| Tachycardia, Ventricular | 1 | 2001 | 1304 | 0.010 |
Why?
|
| Dietary Proteins | 1 | 1996 | 952 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2005 | 3802 | 0.010 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1996 | 851 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2002 | 5247 | 0.010 |
Why?
|
| Fluorescence Polarization | 1 | 1991 | 140 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23445 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2006 | 7967 | 0.010 |
Why?
|
| Diphenylhexatriene | 1 | 1990 | 12 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1973 | 497 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2002 | 9646 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1996 | 1432 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 1996 | 2176 | 0.000 |
Why?
|
| Tonsillitis | 1 | 1967 | 28 | 0.000 |
Why?
|
| Cathartics | 1 | 1988 | 127 | 0.000 |
Why?
|
| Psychotic Disorders | 1 | 2001 | 3223 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1973 | 1768 | 0.000 |
Why?
|
| Mutation | 1 | 2010 | 30052 | 0.000 |
Why?
|
| Stroke | 1 | 2006 | 9757 | 0.000 |
Why?
|
| Puberty | 1 | 1967 | 501 | 0.000 |
Why?
|
| Dental Caries | 1 | 1967 | 428 | 0.000 |
Why?
|
| Self Concept | 1 | 1988 | 1045 | 0.000 |
Why?
|
| Models, Statistical | 1 | 1996 | 5079 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1990 | 3688 | 0.000 |
Why?
|
| Suicide, Attempted | 1 | 1988 | 1402 | 0.000 |
Why?
|
| Obesity | 1 | 2001 | 12947 | 0.000 |
Why?
|